Activity of fosfomycin against Pasteurella.
D000284:Administration, Oral; D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D002645:Chickens; D004096:Dihydrostreptomycin Sulfate / Q000494:pharmacology; D004988:Ethers, Cyclic / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D007279:Injections, Subcutaneous; D051379:Mice; D008826:Microbial Sensitivity Tests; D009675:Novobiocin / Q000494:pharmacology; D009943:Organophosphorus Compounds / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D010118:Oxytetracycline / Q000494:pharmacology; D010325:Pasteurella / Q000187:drug effects* / Q000254:growth & development; D010326:Pasteurella Infections / Q000188:drug therapy / Q000662:veterinary*; D010400:Penicillin G / Q000494:pharmacology / Q000627:therapeutic use; D010403:Penicillin Resistance; D011201:Poultry Diseases / Q000188:drug therapy*; D013307:Streptomycin / Q000627:therapeutic use; D013411:Sulfadiazine / Q000627:therapeutic use; D013752:Tetracycline / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D004988:Ethers, Cyclic; D009943:Organophosphorus Compounds; D013411:Sulfadiazine; D009675:Novobiocin; D013752:Tetracycline; D010400:Penicillin G; D004096:Dihydrostreptomycin Sulfate; D010118:Oxytetracycline; D013307:Streptomycin